Molina Healthcare (MOH) has been making significant strides in the biotech market. Noteworthy happenings include the company's presence in Michael Burryβs top stock picks, its recent earning reports, and the closing of its acquisition of ConnectiCare. Investors such as Mirae Asset Global Investments have been increasing their holdings in this healthcare firm. The company faced a slight setback with a lowered price target from Wells Fargo but even then, its stock has remained strong. The company also experienced strong full-year growth in 2024, despite a few challenges in Q4. The past five years have seen investors earning up to a 144% return from Molina Healthcare. The company also made a major healthcare acquisition by absorbing the 140K-strong member base of ConnectiCare. It has established ambitious goals of hitting $42B by 2025, revealing its robust growth strategy. However, challenges relating to growing medical costs and restrictive credit covenants have been affecting the company's growth. But despite these, many investors and analysts continue to have a bullish outlook on the company.
Molina Healthcare MOH News Analytics from Tue, 23 Jul 2024 07:00:00 GMT to Sat, 15 Feb 2025 07:43:26 GMT -
Rating 7
- Innovation 2
- Information 9
- Rumor -1
